Doxorubicin Liposomal
Doxorubicin Liposomal is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of AIDS-related Kaposi’s sarcoma (KS)
- Ovarian cancer
- Multiple myeloma
- Ovarian cancer (advanced)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Breast cancer (metastatic)
- Cutaneous T-cell lymphomas
- Hodgkin’s lymphoma (salvage treatment)
- Soft tissue sarcoma (advanced)
- Uterine sarcoma (advanced or recurrent)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of AIDS-related Kaposi’s sarcoma (KS)
- Ovarian cancer
- Multiple myeloma
- Ovarian cancer (advanced)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Breast cancer (metastatic)
- Cutaneous T-cell lymphomas
- Hodgkin’s lymphoma (salvage treatment)
- Soft tissue sarcoma (advanced)
- Uterine sarcoma (advanced or recurrent)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved